Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000320017-25-000023
Filing Date
2025-04-25
Accepted
2025-04-25 16:10:43
Documents
18
Period of Report
2025-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A lsta-20250425.htm   iXBRL DEF 14A 732150
3 lsta-20250425_g1.jpg GRAPHIC 16409
4 lsta-20250425_g2.jpg GRAPHIC 7742
5 lsta-20250425_g3.jpg GRAPHIC 106548
6 lsta-20250425_g4.jpg GRAPHIC 100150
7 lsta-20250425_g5.jpg GRAPHIC 4452041
8 lsta-20250425_g6.jpg GRAPHIC 4094354
  Complete submission text file 0000320017-25-000023.txt   19123903

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lsta-20250425.xsd EX-101.SCH 920
20 EXTRACTED XBRL INSTANCE DOCUMENT lsta-20250425_htm.xml XML 93890
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33650 | Film No.: 25874053
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)